Low-dose aspirin and non-aspirin non-steroidal anti-inflammatory drugs and epithelial ovarian cancer survival: a registry-based cohort study in Norway
This study provides further evidence of a potential beneficial effect of post-diagnosis low-dose aspirin use for ovarian cancer survival.
Authors
- Edoardo Botteri (ORCID: https://orcid.org/0000-0002-9023-8068)
- Renée T. Fortner (ORCID: https://orcid.org/0000-0002-1426-8505)
- Kristina Lindemann (ORCID: https://orcid.org/0000-0002-2162-0175)
- Nathalie C. Støer (ORCID: https://orcid.org/0000-0001-8994-9332)
- Hilde Langseth (ORCID: https://orcid.org/0000-0002-9446-4855)
Institutions
- Oslo University Hospital (NO)
- Norwegian Institute of Public Health (NO)
- German Cancer Research Center (DE)
- University of Oslo (NO)
- Heidelberg University (DE)
- Cancer Registry of Norway (NO)
- Imperial College London (GB)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-04-30
- DOI
- https://doi.org/10.1186/s12885-025-14168-y
- Primary Topic
- Inflammatory mediators and NSAID effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Norwegian Institute of Public Health